Persistence and Expression of Human Papillomavirus During Interferon Therapy

Archives of Otolaryngology--Head and Neck Surgery

Volumn 114, Issue 1, 1988, Pages 27-32

  Steinberg, Bettie M ^a   Gallagher, Thomas ^a   Stoler, Mark ^b   Abramson, Allan L ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS RNA;

CLINICAL ARTICLE; ETIOLOGY; HUMAN; PAPILLOMA; PAPILLOMA VIRUS; RESPIRATORY TRACT TUMOR;

ANTIGENS, VIRAL; CAPSID; DNA, VIRAL; HUMAN; INTERFERON TYPE I; LARYNGEAL NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMA; PAPILLOMAVIRUS; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS REPLICATION;

EID: 0023925998     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archotol.1988.01860130031010     Document Type: Article

References (29)

1. Wiranowski-Stewart M, Stewart WE: Interferons: Types alpha, beta and gamma, in Hadden JW, Stewart WE (eds): Lymphokines. Clifton, NJ, Humana Press, 1981, pp 133-148.
2. Breinig MC, Ho M, White L, et al: Effect of prolonged administration of interferon-alpha on pharmacokinetics, fever, lymphocyte proliferative response and NK cell activity. J Interferon Res 1982;2:195-207.
3. Lin SL, Kikuchi T, Pledger WJ, et al: Interferon inhibits the establishment of G[unk]/S-phase transition. Science 1986;233:356-359.
4. Ransohoff RM, Maroney PS, Nayak DP, et al: Effect of human alpha A interferon on influenza virus replication in MDBK cells. J Virol 1985;56:1049-1052.
5. Stadler R, Muller R, Orfanos CE: Effect of recombinant alpha A-interferon on DNA synthesis and differentiation of human keratinocytes in vitro. Br J Dermatol 1986;114:273-277.
6. Gissmann L, Wolnik L, Ikenberg H, et al: Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983;80:560-563.
7. Haglund S, Lundquist P-G, Cantell K, et al: Interferon therapy in juvenile laryngeal papillomatosis. Arch Otolaryngol Head Neck Surg 1981;107:327-332.
8. Bomholt A: Interferon therapy for laryngeal papillomatosis in adults. Arch Otolaryngol Head Neck Surg 1983;109:550-552.
9. Eron LJ, Judson F, Tucker S, et al: Interferon therapy for condylomata acuminata. N Engl J Med 1986;315:1059-1064.
10. Lundquist P-G, Haglund S, Carlsoo B, et al: Interferon therapy in juvenile laryngeal papillomatosis. Otolaryngol Head Neck Surg 1984; 92:386-391.
11. McCabe BF, Clark KF: Interferon and laryngeal papillomatosis: The Iowa experience. Ann Otol Rhinol Laryngol 1983;92:2-7.
12. Turek LP, Byrne JC, Lowy DR, et al: Interferon induces morphologic reversion with elimination of extrachromsomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci USA 1982;79:7914-7918.
13. Krieg P, Amtmann E, Sauer G: The simultaneous extraction of high molecular weight DNA and of RNA from solid tumors. Anal Biochem 1983;134:288-294.
14. De Villiers E-M, Gissmann L, zur Hausen H: Molecular cloning of viral DNA from human genital warts. J Virol 1981;40:932-935.
15. Gissmann L, Diehl V, Schultz-Coulon H-J, et al: Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 1982;44:393-400.
16. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-517.
17. Rigby PW, Dieckmann M, Rhodes C, et al: Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol 1977;113:237-251.
18. Stoler MH, Broker TR: In situ hybridization detection of human papillomavirus DNAs and messenger RNA in genital condyloma and cervical carcinoma. Hum Pathol 1977;17:1250-1258.
19. Lancaster WD, Jenson SB: Evidence for papillomavirus genus-specific antigens and DNA in laryngeal papilloma. Intervirology 1981; 15:204-212.
20. Dartmann K, Schwarz E, Gissmann L, et al: The nucleotide sequence and genome organization of human papilloma virus type II. Virology 1986;151:124-130.
21. Steinberg BM, Topp WC, Schneider PS, et al: Laryngeal papillomavirus infection during clinical remission. N Engl J Med 1983;308:1261-1264.
22. Baglioni C, Maroney PA: Mechanism of action of human interferons: Induction of 2′5′-oligopolymerase. J Biol Chem 1980;255:8390-8393.
23. Clemens MJ, Williams BRG: Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′: A novel oligonucleotide synthesized by interferontreated L cell extracts. Cell 1978;13:565-572.
24. Higashi Y, Sokawa Y: Microinjection of interferon and 2′,5′-oligoadenylate into mouse L cells and their effects on viral growth. J Biochem 1982;91:2021-2028.
25. Lodemann E, Kornhuber B, Gerein V, et al: (2′-5′)oligo(A)synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis. J Interferon Res 1984;4:283-290.
26. Rice AP, Roberts WK, Kerr IM: 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication. J Virol 1984; 50:220-228.
27. Mounts P, Wu T-C, Leventhal B, et al: Analysis of human papillomavirus type 6 in the respiratory and genital tracts during interferon therapy, in Howley PM, Broker TR (eds): Papillomaviruses: Molecular and Clinical Aspects. New York, Alan R Liss Inc, 1985, pp 137-154.
28. Steinberg BM, Abramson AL, Horowitz B: Effects of alpha-interferon on cultured laryngeal papilloma cells, in Howley PM, Broker TR (eds): Papillomaviruses: Molecular and Clinical Aspects. New York, Alan R Liss Inc, 1985, pp 413-426.
29. Davison P, Liu S, Karasek M: Limitations in the use of [3H]thymidine incorporation into DNA as an indicator of epidermal keratinocyte proliferation in vitro. Cell Tissue Kinet 1979;12:605-614.